CerilliantLog In | Recently Purchased | Favorites | My COAs | Cart (0)Cerilliant ISO


23-July-2013
Introducing Etizolam-D3, the latest benzodiazepine internal standard from Cerilliant.


Etizolam-D3, 1 mL, 100 ug/mL E-082
100 µg/mL in Methanol

An internal standard suitable for quantitation of etizolam levels in urine or other matrices by LC/MS or GC/MS in forensic analysis, clinical toxicology, or urine drug testing applications. Etizolam, sold under brand names such as Etilaam, Etizola, or Depas, is a benzodiazepine analog used for the short-term treatment of insomnia, anxiety, or panic attacks. Etizolam is also sold on the designer drug market with cases of abuse noted in Europe and the US.

Coming soon, Cerilliant will introduce the following benzodiazepine internal standards:
 
P-093 Phenazepam-D4
N-088 Norchlordiazepoxide-D5



Cerilliant Certified Solution Standards and Certified Spiking Solutions are manufactured to the highest industry standards. We are accredited to ISO Guide 34 and ISO/IEC 17025 & certified to ISO 13485 and ISO 9001. Our quality system also incorporates cGMP and GLP requirements


All New Product Announcements


© 2018 Cerilliant Corporation | 811 Paloma Drive, Suite A | Round Rock, Texas 78665
Sigma-Aldrich is a subsidiary of Merck KGaA, Darmstadt, Germany
Products | News/Events | Sitemap | Privacy Policy | EHS Policy | Terms & Conditions | Contact
Follow Us: Cerilliant Linkedin LinkedIn